Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mRNA
Biotech
Moderna’s norovirus vaccine plans in limbo in wake of ph. 3 miss
Moderna has scrapped plans to enroll a new cohort in a trial of its norovirus vaccine and instead will meet with regulators to decide on next steps.
Marissa Russo
Nov 6, 2026 9:51am
Novartis pens $7.8B deal for Abogen's in vivo autoimmune TCE
Oct 2, 2026 4:24am
Have Moderna, Merck kicked off a 'personalized med revolution'?
Sep 11, 2026 9:00am
GSK plans phase 3 after mRNA flu vaccine beats standard shots
Sep 1, 2026 5:43am
BioNTech, Genentech cancel ph. 2 test of personalized cancer vax
Aug 28, 2026 1:50pm
With mRNA back in the spotlight, tRNA shows potential
Aug 27, 2026 2:00pm